postoperative nausea and vomiting

(redirected from Post-operative nausea and vomiting)
Also found in: Acronyms.

postoperative nausea and vomiting (PONV)

nausea and vomiting occurring after a surgical procedure.
References in periodicals archive ?
In our study, given the substantial and significant efficacy of Propofol and Ondansetron in reducing nausea and vomiting after laparoscopic surgery is suggested that followed anesthesia of patients should be with Propofol, and Ondansetron and Dexametasone should be used together in order to reduce post-operative nausea and vomiting in the recovery room and within first 24 hours more.
VAS scores for post-operative nausea and vomiting (PONY) at different time intervals in the 3 groups Time Intervals (h) Group A Group B 0 Early PONV 0.
In 2002, a double-blind, randomized, placebo-controlled study in Austria found that with minor gynecological surgery, incidents of post-operative nausea and vomiting were reduced with Korean hand acupressure (a needle-free procedure that involves the application of pressure using acupressure "seeds").
Aloxi is currently being evaluated in a clinical program designed to evaluate its safety and efficacy in post-operative nausea and vomiting, but it is not approved for this indication.
The results of this study are important as they show effective dose of antiemetics that can substantially prevent post-operative nausea and vomiting," said Dr.
NEW YORK -- In an investigational study clinical data shows Roche's Kytril(R) (granisetron) to be effective in the prevention of post-operative nausea and vomiting (PONV) at doses as low as 0.
Nasdaq:MOGN), a biopharmaceutical company focused in oncology and acute care, and its partner HELSINN HEALTHCARE SA, a privately owned Swiss pharmaceutical group, today announced that a supplemental New Drug Application (sNDA) for Aloxi([R]) (palonosetron hydrochloride) Injection for the prevention of post-operative nausea and vomiting (PONV) has been submitted to the U.
Food and Drug Administration (FDA) granted approval of its antiemetic, Kytril(R) Injection (granisetron hydrochloride) for both the prevention and treatment of post-operative nausea and vomiting (PONV).
Zensana[TM] is an oral spray formulation of ondansetron targeted for the prevention of chemotherapy-, radiotherapy-induced and post-operative nausea and vomiting.
Zensana(TM) is an oral spray formulation of ondansetron that is indicated for the prevention of chemotherapy- and radiation-induced and post-operative nausea and vomiting.
In addition, Aloxi is being developed for the prevention of post-operative nausea and vomiting (PONV), but is not approved for this indication.
Nasdaq: MOGN), a biopharmaceutical company focused in oncology and acute care, and its partner HELSINN HEALTHCARE SA, a privately owned Swiss pharmaceutical group, today announced the successful completion of two phase 3 trials of Aloxi[R] (palonosetron hydrochloride) Injection for the prevention of post-operative nausea and vomiting (PONV).